I have never seen any published studies testing absorption through a patch, only by injection, says Dr
85 Dulaglutide 1.5 mg has demonstrated non-inferiority in diabetes control compared to liraglutide 1.8 mg, and comparable weight reduction efficacy to oral SEMA (Orforglipron) 3 mg
GLP-1 medications are not approved for use during pregnancy or while actively trying to conceive
Furthermore, GLP-1 agonists offer health benefits that transcend weight management, including improved glycemic control and potential protective effects against cardiovascular diseases
The dual GLP-1/GIP receptor agonist DA4-JC shows superior protective properties compared to the GLP-1 analogue Liraglutide in the APP/PS1 mouse model of Alzheimers disease
More serious but less common risks include pancreatitis (characterized by severe abdominal pain that may radiate to the back), gallbladder disease, and acute kidney injury from volume depletion